vs
Side-by-side financial comparison of M/I HOMES, INC. (MHO) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
M/I HOMES, INC. is the larger business by last-quarter revenue ($1.1B vs $622.0M, roughly 1.8× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 5.6%, a 28.9% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -4.8%). Over the past eight quarters, M/I HOMES, INC.'s revenue compounded faster (4.7% CAGR vs 4.6%).
M/I Homes, Inc. is a leading U.S. residential construction company that designs, builds and sells single-family homes, townhomes and duplexes across multiple U.S. states. It caters to entry-level, move-up and luxury homebuyers, offering energy-efficient designs, flexible floor plans and personalized customization options.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
MHO vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $622.0M |
| Net Profit | $64.0M | $214.2M |
| Gross Margin | 17.4% | — |
| Operating Margin | 6.5% | 62.4% |
| Net Margin | 5.6% | 34.4% |
| Revenue YoY | -4.8% | 4.8% |
| Net Profit YoY | -52.1% | 2.9% |
| EPS (diluted) | $2.42 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $976.1M | $568.2M | ||
| Q4 24 | $1.2B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.0B | $568.0M |
| Q4 25 | $64.0M | $214.2M | ||
| Q3 25 | $106.5M | $288.2M | ||
| Q2 25 | $121.2M | $30.2M | ||
| Q1 25 | $111.2M | $238.3M | ||
| Q4 24 | $133.5M | $208.2M | ||
| Q3 24 | $145.4M | $544.0M | ||
| Q2 24 | $146.7M | $102.0M | ||
| Q1 24 | $138.1M | $4.8M |
| Q4 25 | 17.4% | — | ||
| Q3 25 | 24.5% | — | ||
| Q2 25 | 24.7% | — | ||
| Q1 25 | 25.9% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 27.9% | — | ||
| Q1 24 | 27.1% | — |
| Q4 25 | 6.5% | 62.4% | ||
| Q3 25 | 12.0% | 70.1% | ||
| Q2 25 | 13.4% | 36.3% | ||
| Q1 25 | 14.4% | 94.0% | ||
| Q4 24 | 13.6% | 60.9% | ||
| Q3 24 | 15.9% | — | ||
| Q2 24 | 16.8% | 50.2% | ||
| Q1 24 | 16.6% | -13.0% |
| Q4 25 | 5.6% | 34.4% | ||
| Q3 25 | 9.4% | 47.3% | ||
| Q2 25 | 10.4% | 5.2% | ||
| Q1 25 | 11.4% | 41.9% | ||
| Q4 24 | 11.1% | 35.1% | ||
| Q3 24 | 12.7% | 96.3% | ||
| Q2 24 | 13.2% | 19.0% | ||
| Q1 24 | 13.2% | 0.8% |
| Q4 25 | $2.42 | $0.49 | ||
| Q3 25 | $3.92 | $0.67 | ||
| Q2 25 | $4.42 | $0.07 | ||
| Q1 25 | $3.98 | $0.55 | ||
| Q4 24 | $4.71 | $0.46 | ||
| Q3 24 | $5.10 | $1.21 | ||
| Q2 24 | $5.12 | $0.23 | ||
| Q1 24 | $4.78 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $3.2B | $9.7B |
| Total Assets | $4.8B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $3.2B | $9.7B | ||
| Q3 25 | $3.1B | $9.6B | ||
| Q2 25 | $3.1B | $9.5B | ||
| Q1 25 | $3.0B | $9.8B | ||
| Q4 24 | $2.9B | $10.3B | ||
| Q3 24 | $2.8B | $10.3B | ||
| Q2 24 | $2.7B | $9.8B | ||
| Q1 24 | $2.6B | $9.9B |
| Q4 25 | $4.8B | $19.6B | ||
| Q3 25 | $4.8B | $19.3B | ||
| Q2 25 | $4.7B | $18.3B | ||
| Q1 25 | $4.6B | $17.6B | ||
| Q4 24 | $4.5B | $18.2B | ||
| Q3 24 | $4.5B | $18.0B | ||
| Q2 24 | $4.3B | $17.7B | ||
| Q1 24 | $4.2B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.7M | $827.1M |
| Free Cash FlowOCF − Capex | $-13.0M | — |
| FCF MarginFCF / Revenue | -1.1% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | -0.14× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $127.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.7M | $827.1M | ||
| Q3 25 | $43.4M | $702.6M | ||
| Q2 25 | $37.8M | $364.0M | ||
| Q1 25 | $64.9M | $596.1M | ||
| Q4 24 | $104.4M | $742.5M | ||
| Q3 24 | $-67.9M | $703.6M | ||
| Q2 24 | $27.5M | $658.2M | ||
| Q1 24 | $115.8M | $664.6M |
| Q4 25 | $-13.0M | — | ||
| Q3 25 | $42.0M | — | ||
| Q2 25 | $35.1M | — | ||
| Q1 25 | $63.5M | — | ||
| Q4 24 | $102.3M | — | ||
| Q3 24 | $-68.5M | — | ||
| Q2 24 | $22.0M | — | ||
| Q1 24 | $115.5M | — |
| Q4 25 | -1.1% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | -6.0% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 11.0% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | -0.14× | 3.86× | ||
| Q3 25 | 0.41× | 2.44× | ||
| Q2 25 | 0.31× | 12.06× | ||
| Q1 25 | 0.58× | 2.50× | ||
| Q4 24 | 0.78× | 3.57× | ||
| Q3 24 | -0.47× | 1.29× | ||
| Q2 24 | 0.19× | 6.45× | ||
| Q1 24 | 0.84× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MHO
| Southern Homebuilding | $615.6M | 54% |
| Northern Homebuilding | $503.9M | 44% |
| Financial Service | $27.8M | 2% |
| Land | $4.7M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
